topic0
Tumour NOS [neop] 0.00830402777695
Radiofrequency Ablation [topp] 0.00348994036052
Higher [qlco] 0.00249609301995
DIAGNOSIS [fndg] 0.00230922169696
Including [ftcn] 0.00228475705394
Survival [acty] 0.00669802746669
Group [idcn] 0.00295741981805
Based [ftcn] 0.00274049413369
Association [menp] 0.00281639098181
HEPATITIS C VIRUS [virs] 0.0110695677205
LIVER [bpoc] 0.00800941555458
Performed [ftcn] 0.00349906791057
Independent [idcn] 0.00283569055494
Imaging [diap] 0.00260339015974
Study [mnob] 0.00597390772438
Mortality [qnco] 0.00458639426935
Suggest [idcn] 0.00273038861157
Conclusions [idcn] 0.00416798116953
Low [qlco] 0.00247928563115
Methods [inpr] 0.00629289778601
Risk Factors [qnco] 0.00761563500266
Cases [ftcn] 0.0037923544511
Treated [ftcn] 0.00270685154269
YEARS [tmco] 0.00470406408536
MELD score [clna] 0.00233739752414
included [ftcn] 0.00287778023977
therapy [ftcn] 0.00440886331931
YEAR [tmco] 0.00384298096359
Hepatectomy [topp] 0.00525832013909
Related [qlco] 0.00361430345854
Identified [qlco] 0.0026042302979
Odds Ratio [qnco] 0.00240620483805
treatment [ftcn] 0.00441473641183
CIRRHOSIS [dsyn] 0.00570182457038
Compared [acty] 0.00355861571234
Pathology [bmod] 0.00342415175765
Extrahepatic [spco] 0.00307998468884
CANCER [neop] 0.00381115550412
Increased [qnco] 0.00357364035643
Transarterial Chemoembolization [topp] 0.00324390372375
topic1
Tumour NOS [neop] 0.00308547856515
Important [qlco] 0.00313761602435
Radiofrequency Ablation [topp] 0.00465181713509
Higher [qlco] 0.00330593264301
Present [qnco] 0.0024374834808
Based [ftcn] 0.00246141589753
Survival [acty] 0.0096060604424
Group [idcn] 0.00433533918544
resection [topp] 0.00512152166452
Including [ftcn] 0.00288672472194
findings [ftcn] 0.00262403963021
HCV [virs] 0.00262141921539
LIVER [bpoc] 0.00750410546016
Performed [ftcn] 0.0031897639189
SERUM [bdsu] 0.00272925089428
Independent [idcn] 0.0038954914661
LOCAL [spco] 0.00235361379888
Study [mnob] 0.00604269960643
control [qlco] 0.00277745083145
rights [qlco] 0.0027907688271
Methods [inpr] 0.00530884925202
Risk Factors [qnco] 0.0108753155668
Cases [ftcn] 0.00463300367965
Intrahepatic Cholangiocarcinoma [neop] 0.00702689397499
Treated [ftcn] 0.00240084302268
YEARS [tmco] 0.00603336013374
Mortality [qnco] 0.00269863599274
therapy [ftcn] 0.00246526724403
Liver Transplantation [topp] 0.00314274610544
Human [humn] 0.00263172385166
YEAR [tmco] 0.00555160496385
Hepatectomy [topp] 0.00365968451998
Related [qlco] 0.00279285123396
Identified [qlco] 0.00290490040888
treatment [ftcn] 0.00599353912574
CIRRHOSIS [dsyn] 0.00873235847779
Reserve [acty] 0.00261427580673
Compared [acty] 0.00462079610889
Increased [qnco] 0.00374248303163
HCC [neop] 0.00581509173559
topic2
Tumour NOS [neop] 0.00508202443067
Morbidity [qnco] 0.00313238057157
Radiofrequency Ablation [topp] 0.00275572230786
Median [spco] 0.0029205962589
Survival [acty] 0.0109222427105
Group [idcn] 0.0077488617018
resection [topp] 0.00341358065202
CI [geoa] 0.00435079694196
Nonalcoholic Steatohepatitis [dsyn] 0.00399545642269
Hepatic [blor] 0.00261796866418
Hepatectomy [topp] 0.00357194796374
Performed [ftcn] 0.00365030348802
DIAGNOSIS [fndg] 0.00416215475476
Invasion [fndg] 0.00308401767723
Study [mnob] 0.00986037512926
Mortality [qnco] 0.00542994790566
Independent [idcn] 0.00305031763495
Conclusions [idcn] 0.00362698315519
FIBROSIS [patf] 0.004264725552
Compared [acty] 0.00395363884356
Trial [resa] 0.0025649295805
Cases [ftcn] 0.00393342574847
Treated [ftcn] 0.00257214520565
YEARS [tmco] 0.00388746148872
Higher [qlco] 0.0026336619585
included [ftcn] 0.00545698119276
Cholangiocarcinoma [neop] 0.00287229974154
YEAR [tmco] 0.00459534219047
LIVER [bpoc] 0.00626615435834
Related [qlco] 0.00490235014613
Focal Nodular Hyperplasia [dsyn] 0.00289178715007
Identified [qlco] 0.00291543354283
treatment [ftcn] 0.00679952933759
CIRRHOSIS [dsyn] 0.00476926867032
Complications [patf] 0.00347615091349
Methods [inpr] 0.00617097327102
Preoperative [tmco] 0.00294335996949
Liver Cancer [neop] 0.00280881135149
Risk Factors [qnco] 0.0122722414977
Increased [qnco] 0.0042674960832
topic3
Tumour NOS [neop] 0.00419641346484
Important [qlco] 0.00259549775472
Radiofrequency Ablation [topp] 0.0152766137224
Groups [idcn] 0.00386285076048
Survival [acty] 0.00584779810462
Group [idcn] 0.00781329676092
resection [topp] 0.0111778636381
Including [ftcn] 0.00287873937787
HEPATITIS C VIRUS [virs] 0.00478623460844
SMALL [qnco] 0.00278638534032
Hepatic [blor] 0.00861133139339
Performed [ftcn] 0.0030077866975
HEPATITIS B VIRUS [virs] 0.00946279511417
Observed [ftcn] 0.0029832799755
Independent [idcn] 0.00441073527085
Invasion [fndg] 0.0048776678585
Study [mnob] 0.00976823390299
LOWER [spco] 0.00326840784998
Conclusions [idcn] 0.00376675377939
Methods [inpr] 0.00379927662382
Infected [fndg] 0.00320695031409
Risk Factors [qnco] 0.00785500613586
Cases [ftcn] 0.00498584867121
Treated [ftcn] 0.00302259506961
YEARS [tmco] 0.00594205302325
Cholangiocarcinoma [neop] 0.00279678237405
Liver Transplantation [topp] 0.00430820863698
YEAR [tmco] 0.00450061777447
LIVER [bpoc] 0.00805817851849
Related [qlco] 0.00793266243925
Surgery [bmod] 0.00296641020214
Percutaneous [spco] 0.00325611140175
treatment [ftcn] 0.00482829137575
CIRRHOSIS [dsyn] 0.0097057342425
Increased [qnco] 0.00276231045873
Levels [qlco] 0.00353561558378
Compared [acty] 0.00473099694739
CANCER [neop] 0.00285147375963
Curative [cnce] 0.00435993146199
HCC [neop] 0.00281962040917
topic4
Tumour NOS [neop] 0.00796059510555
Radiofrequency Ablation [topp] 0.00543025588064
Survival [acty] 0.00428794558953
Group [idcn] 0.00256717118156
resection [topp] 0.00450659661432
CHOLANGITIS, PRIMARY SCLEROSING [dsyn] 0.00256908307371
Based [ftcn] 0.00344967599851
Hazard Ratio [qnco] 0.00290416122673
lesions [fndg] 0.00395488052821
Performed [ftcn] 0.00348392369299
SERUM [bdsu] 0.00361306916289
LOCAL [spco] 0.00301295623755
Study [mnob] 0.0066944214237
Conclusions [idcn] 0.00348425035323
Methods [inpr] 0.00503958137036
Risk Factors [qnco] 0.00512163325968
Cases [ftcn] 0.00911363543203
Intrahepatic Cholangiocarcinoma [neop] 0.00635635141039
Hepatocellular Carcinomas [neop] 0.0027418685446
Treated [ftcn] 0.00300829399124
YEARS [tmco] 0.00546744622046
Cholangiocarcinoma [neop] 0.00444998933433
Induced [ftcn] 0.00364258039495
Image [inpr] 0.00321875657984
YEAR [tmco] 0.00331988403981
LIVER [bpoc] 0.00804403072092
Tumors [neop] 0.00259734379048
Range [qnco] 0.00246483249344
Identified [qlco] 0.00276049548321
treatment [ftcn] 0.00402819631256
CIRRHOSIS [dsyn] 0.00417657161809
Complications [patf] 0.00298890381463
Criteria [inpr] 0.00341433095845
Detected [fndg] 0.00271019936816
Compared [acty] 0.00365348226509
Pathology [bmod] 0.00398253505587
TIME [tmco] 0.00343821187734
Increased [qnco] 0.0039628339034
HCC [neop] 0.00588998069645
Liver Transplantation [topp] 0.00588290545976
topic5
Tumour NOS [neop] 0.00396886000235
Higher [qlco] 0.00344197405069
Present [qnco] 0.00243240833261
Including [ftcn] 0.00412132682079
Survival [acty] 0.00306330610696
resection [topp] 0.00383130768326
DIABETES MELLITUS [dsyn] 0.00369915753392
Based [ftcn] 0.00401850809002
Hazard Ratio [qnco] 0.00281211602234
Hepatic [blor] 0.0026642206613
Subject [grup] 0.00299914699175
Risk Factor [qnco] 0.00277450582193
Association [menp] 0.00292186289187
Performed [ftcn] 0.0024777423276
HEPATITIS B VIRUS [virs] 0.00648456406743
Observed [ftcn] 0.00319507745099
Reserve [acty] 0.00263190278022
SERUM [bdsu] 0.00286383040285
Independent [idcn] 0.00410494339638
Study [mnob] 0.00907404690655
DIAGNOSIS [fndg] 0.00331065281686
Conclusions [idcn] 0.00405336948621
Methods [inpr] 0.00568187224959
Risk Factors [qnco] 0.0103300325735
Cases [ftcn] 0.00605762214695
YEARS [tmco] 0.00804836518711
Mutations [genf] 0.00256573959191
therapy [ftcn] 0.00277503932672
Liver Transplantation [topp] 0.00257621862597
LIVER [bpoc] 0.00543002801603
Related [qlco] 0.00296488353196
Genotype [orga] 0.00272945269484
Identified [qlco] 0.00287015495022
treatment [ftcn] 0.00976825732819
CIRRHOSIS [dsyn] 0.00334983256888
Levels [qlco] 0.00741638114603
Compared [acty] 0.00342595738393
Pathology [bmod] 0.00408879905511
CANCER [neop] 0.00523396905664
Increased [qnco] 0.0038142701416
topic6
Tumour NOS [neop] 0.00525359515923
ABLATION [topp] 0.00295335897363
Suggest [idcn] 0.00246570683155
Higher [qlco] 0.00304620700705
Survival [acty] 0.00654946892377
Group [idcn] 0.003936265659
resection [topp] 0.00419628925796
Including [ftcn] 0.00255571797995
CI [geoa] 0.00284489292623
Hepatic [blor] 0.00416671725601
Hepatectomy [topp] 0.0030533169113
Performed [ftcn] 0.00330714767974
HEPATITIS B VIRUS [virs] 0.00312801500088
Observed [ftcn] 0.0029515382449
DIAGNOSIS [fndg] 0.00447192614234
Invasion [fndg] 0.0044642117349
Study [mnob] 0.00956895909197
Mortality [qnco] 0.00663119035626
Independent [idcn] 0.00446306435272
Nonalcoholic Fatty Liver Disease [dsyn] 0.00490096580809
Methods [inpr] 0.00487035392937
Risk Factors [qnco] 0.00662482141772
Cases [ftcn] 0.00723435470371
OBESITY [dsyn] 0.00247412036145
control [qlco] 0.00337619772071
Cholangiocarcinoma [neop] 0.00247696716129
Liver Transplantation [topp] 0.00238948811987
YEAR [tmco] 0.00358167138745
LIVER [bpoc] 0.00570222581584
Related [qlco] 0.00674443835082
Tumors [neop] 0.00225500884803
Postoperative [tmco] 0.00282705285407
treatment [ftcn] 0.00381961371828
CIRRHOSIS [dsyn] 0.0049882626134
FIBROSIS [patf] 0.00247693621636
Compared [acty] 0.00350249065053
Pathology [bmod] 0.0030332072217
CANCER [neop] 0.00373137519088
Increased [qnco] 0.00497138228186
Transarterial Chemoembolization [topp] 0.00297786562318
topic7
Tumour NOS [neop] 0.00509412500475
Important [qlco] 0.00303475376786
Treated [ftcn] 0.00315204269425
Median [spco] 0.00416463399078
Survival [acty] 0.0108690076854
Group [idcn] 0.00716555538635
resection [topp] 0.00664932782544
HEPATITIS C VIRUS [virs] 0.0029047224573
Hazard Ratio [qnco] 0.00345409926789
HCV [virs] 0.00264081417912
Intrahepatic [spco] 0.00403796831441
Hepatic [blor] 0.00327459271905
LIVER [bpoc] 0.006629014799
Arterial [bpoc] 0.00263036844136
Performed [ftcn] 0.00395675256227
HEPATITIS B VIRUS [virs] 0.00335797597659
Independent [idcn] 0.00417158125467
Invasion [fndg] 0.00317374040313
Study [mnob] 0.0109934044155
LOWER [spco] 0.00296526960333
Suggest [idcn] 0.00272914187135
Conclusions [idcn] 0.0036757039475
Nonalcoholic Fatty Liver Disease [dsyn] 0.00571492943535
Methods [inpr] 0.00629668670388
Cases [ftcn] 0.00539996942835
chemoembolisation [topp] 0.00296063453011
YEARS [tmco] 0.00736333605196
Mortality [qnco] 0.00275216934623
Cholangiocarcinoma [neop] 0.00384790316595
Liver Transplantation [topp] 0.00569087809541
YEAR [tmco] 0.00595201672487
Hepatectomy [topp] 0.00410647394505
Related [qlco] 0.00345973716207
CCA [cgab] 0.00266367241678
Identified [qlco] 0.00403057222593
Portal Vein Thrombosis [dsyn] 0.0036483150537
treatment [ftcn] 0.00736690201881
CIRRHOSIS [dsyn] 0.00397086870372
Risk Factors [qnco] 0.00573082095275
Tumors [neop] 0.00314494583904
topic8
Tumour NOS [neop] 0.00354902674866
HCV [virs] 0.00664739913538
Compared [acty] 0.00677202218463
Radiofrequency Ablation [topp] 0.0024835015547
Median [spco] 0.00229946750835
Groups [idcn] 0.00465150483643
Survival [acty] 0.00683869837307
Group [idcn] 0.00485768327096
resection [topp] 0.00315945789894
Including [ftcn] 0.00313878253003
HEPATITIS C VIRUS [virs] 0.00913481695233
Criteria [inpr] 0.0031355532892
HEPATITIS B VIRUS [virs] 0.00342440272987
SERUM [bdsu] 0.00280066111766
DIAGNOSIS [fndg] 0.00320391394191
Study [mnob] 0.00612967399184
Mortality [qnco] 0.00295264356359
Independent [idcn] 0.00232094589076
Conclusions [idcn] 0.00451282308992
Methods [inpr] 0.00679706899931
Infected [fndg] 0.00285277440342
CANCER [neop] 0.00357095023845
Cases [ftcn] 0.00577277479371
YEARS [tmco] 0.00490623445863
Molecular [qlco] 0.00254900737729
Human [humn] 0.00239272168714
Liver Transplantation [topp] 0.00558332390818
YEAR [tmco] 0.0052954770243
LIVER [bpoc] 0.00566540493827
LIVER CIRRHOSIS [dsyn] 0.00230689070915
Related [qlco] 0.00912319441974
Identified [qlco] 0.0028233618215
Progression [patf] 0.00331241266604
treatment [ftcn] 0.00523076656509
CIRRHOSIS [dsyn] 0.0117551561623
Transplantation [topp] 0.00241095711309
Risk Factors [qnco] 0.00863799402701
Performed [ftcn] 0.00261113868299
Based [ftcn] 0.00276537595151
Increased [qnco] 0.00320594711433
topic9
Performed [ftcn] 0.00302347505688
HCC [neop] 0.00279104096502
Radiofrequency Ablation [topp] 0.00387602446714
Transcatheter [spco] 0.00331490849781
Present [qnco] 0.0031060052153
Survival [acty] 0.00941212007481
Group [idcn] 0.00463359032856
resection [topp] 0.00706778575516
Including [ftcn] 0.00271044605389
Tumour size [spco] 0.00301312396159
Prognostic [inpr] 0.00281875526471
Hepatic [blor] 0.00482255531258
Criteria [inpr] 0.00585209056605
SERUM [bdsu] 0.00286301561442
Independent [idcn] 0.00456339425626
LOCAL [spco] 0.00394624780699
Study [mnob] 0.0084642629067
DIAGNOSIS [fndg] 0.00329682926984
Conclusions [idcn] 0.00322147520756
rights [qlco] 0.00278959582169
Methods [inpr] 0.00619079187461
Risk Factors [qnco] 0.00847204612634
chemoembolisation [topp] 0.00278528794945
Arterial [bpoc] 0.00337723723947
Treated [ftcn] 0.00305044633627
YEARS [tmco] 0.00917935389173
Liver Transplantation [topp] 0.00286224009452
YEAR [tmco] 0.00660642411443
LIVER [bpoc] 0.00458437677757
Related [qlco] 0.00414798383478
Identified [qlco] 0.00293982835849
Progression [patf] 0.00330398836645
treatment [ftcn] 0.00588423029115
CIRRHOSIS [dsyn] 0.00654771760487
Single [popg] 0.00276252858546
Compared [acty] 0.00377363574207
Pathology [bmod] 0.00309004202469
Increased [qnco] 0.00334116758783
Transarterial Chemoembolization [topp] 0.00302700204131
Evaluated [hlca] 0.00274948911615
